Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Clinical Trial Evaluating TheraSphere® in Patients With Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy

NCT01483027 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT01483027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01483027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Clinical Trial Evaluating TheraSphere® in Patients With Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2012
Completion date
August 31, 2020
Enrollment
428 (actual)
Sites
131

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic